Sounds like it could be game over next year

Quote


















Anonymous said:
Your CEO doesnt sound optimistic

http://www.regulations.gov/#!documentDetail;D=CMS-2013-0155-0454
Click to expand...

On Novemeber 1, 2013 we will all learn if the proposed drastic custs proposed by CMS to the PFS and CLFS become permanent.

It's a good letter. The very survival of NeoGenomics, among many other labs, depends on the ability of CAP to fight the proposed massive reimbursement cuts. I've heard it's a 50/50 toss up regarding the outcome of this proposed cut.

If the cuts do occur, it really is lights out.
 






As a competitor to Neogenomics, I applaud Mr. Van Ort for his comment. The letter was well written and is "on point". Not sure who was on that committee at CMS that decided these calculations were appropriate.

I agree that if these cuts are made, the esoteric laboratory industry will be challenged to survive.
 






Anonymous said:
As a competitor to Neogenomics, I applaud Mr. Van Ort for his comment. The letter was well written and is "on point". Not sure who was on that committee at CMS that decided these calculations were appropriate.

I agree that if these cuts are made, the esoteric laboratory industry will be challenged to survive.
Click to expand...

If labs (like the one I suspect you represent) were not so greedy and had not gone to even more expensive, though unnecessary testing, this problably would not be happening. As a former employee of a cancer testing lab, I know that most patient specimens are normal. Doctors are over-testing, and cancer labs are trying to squeeze every penny from patients and insurance companies. It is unfortunate for the workers at these labs, but I couldn't care less if the owners/ceos of these companies have to sell apples on the street.
 






There is a lot of blame to go around. No doubt many labs have been pushing expensive, unnecessary testing for a long time.

But...

We need better lab tests to prevent overtreatment of patients with different types of tumors. Prognostic tests that solve the dilema of prostate, cervical, breast cancers and so on. My fear is that many speciality labs, who likely would make these tests, are gonna bite the dust if these cuts go through. Inovation will come from radiology instead of laboratory.
 












No, we are not. We have a commercial lab (you will see it in 2014).
Will wait until the cuts cripple those who buy our kits/probes then decide who to grab.
Neo would be a decent choice tho - Neo IT sucks but good menu.
 






















































Anonymous said:
LOL again (different poster BTW)
Click to expand...

What about this do you guys not get? The CMS ax is falling and most labs simply can't afford to stay in business. Neo and possibly Clarient (with GE) have bigger pockets than do the other podunk labs. Stay in you dream world and see who comes out on top when these cuts go into effect. Like I say, see who is laughing then.
 






Had a client last week tell me that now CSI is trying to offer tech FISH. Great timing guys, push that tech product hard for the next six weeks and then you can use that million dollar equipment as a paperweight. What a joke!
 






Anonymous said:
Had a client last week tell me that now CSI is trying to offer tech FISH. Great timing guys, push that tech product hard for the next six weeks and then you can use that million dollar equipment as a paperweight. What a joke!
Click to expand...

That is hilarious. Their owner has a reputation for slamming Neo. Maybe he is about to eat crow.
 






Top Bottom
Back
Quote